Navigation Links
Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution
Date:12/9/2009

SANTA MONICA, Calif. and WALTHAM, Mass., Dec. 10 /PRNewswire/ -- Reprints Desk, Inc., and QUOSA, Inc., today announced that Cubist Pharmaceuticals has become the first shared customer to activate integration between Reprints Desk's STM Document Delivery service with QUOSA's Virtual Library, which facilitates copyright-compliant article archiving and scientific literature re-use. The integrated solution features integration with Rightsphere, the rights advisory and management tool from Copyright Clearance Center (CCC), which already integrates independently with both Reprints Desk and QUOSA.

"The integration of QUOSA's powerful solution for archiving and sharing scientific journal articles with Reprints Desk's ultra-rapid document delivery service was a logical collaboration for delivering the efficiency and compliance benefits we've been seeking to enhance our eLiterature services," said A. Amyas Huston, Senior Manager of Medical Communications at Cubist. "With QUOSA already deployed and Reprints Desk delivery not requiring any platform fees or any IT information technology involvement from Cubist, the implementation within our workflow processes was fast and seamless."

Lexington MA-based Cubist Pharmaceuticals has been a QUOSA customer and a Reprints Desk customer since 2007. QUOSA serves a large and rapidly growing subscriber-base at leading pharmaceutical, biotechnology and other life-science companies, with solutions for efficiently managing and monitoring scientific literature. Reprints Desk earned the top ranking overall and in every category in the 2008 Document Delivery Best Practices and Vendor Scorecard by analyst and advisory firm Outsell, Inc., and scored a 97% customer satisfaction rating in Dun & Bradstreet's 2009 Open Ratings survey of existing Reprints Desk customers.

For more information about Reprints Desk and its STM Document Delivery service, visit the Reprints Desk website online at www.reprintsdesk.com. For additional information about QUOSA's solutions for efficiently managing and monitoring scientific literature and the QUOSA Virtual Library, visit www.quosa.com.

About QUOSA®

QUOSA Inc. is a specialist software company focused on literature management workflows and archives, which include full-text articles and patents. With a large and rapidly growing subscriber-base at leading pharmaceutical, biotechnology and other life-science companies, and in research and medical centers, QUOSA's applications are used to compress the time to insight and action across the key functions of the innovation enterprise. For more information about QUOSA, please visit the website at www.quosa.com.

About Reprints Desk®

Reprints Desk, Inc. (www.reprintsdesk.com) is a business software and information services company that simplifies how research-intensive companies and other organizations procure, manage and share journal articles and other copyright-protected content. The company's content workflow and compliance solutions help customers effectively use peer-reviewed literature in research, regulatory submissions, and product promotions. A channel supplier for more than 100 scientific, technical, and medical (STM) publishers, Reprints Desk earned the #1 ranking in the 2008 Document Delivery Vendor Scorecard by Outsell, Inc., and currently serves companies in life sciences, energy, aerospace, industrial products, consumer packaged goods, food and beverages, information technology, legal, and government. Reprints Desk is a Derycz Scientific company. For more information about Reprints Desk, contact Ian Palmer at +1 (707) 658-1931.


Public and Media Relations Contacts:
------------------------------------

Ian Palmer, Head of Marketing
Reprints Desk, Inc. | +1 707.658.1931
ipalmer@reprintsdesk.com

SOURCE Reprints Desk, Inc.


'/>"/>
SOURCE Reprints Desk, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lees Pharmaceuticals
2. BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors
3. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
4. Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis
5. Rib-X Pharmaceuticals Expands License Agreement with Yale University on New Ribosome Technology
6. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
7. Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals Universal Flu Vaccine
8. Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference
9. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
10. Jazz Pharmaceuticals Appoints Kathryn Falberg as Chief Financial Officer
11. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amiras Lead DP2 Antagonist, AM211
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor ... market is expected to grow at a CAGR of 27.1% ... 38.7% in the second half of the forecast period. The market ... to 2027. The market is estimated at $1,058 million in 2016, ... ...
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... January 19, 2017 New ... to Address Motor Symptoms and Motor Complications in ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) C ... European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots ... scientists from around the world, announces the launch of its newly redesigned website. ... portal to research breakthroughs and trending news, vital information on upcoming virtual events ...
(Date:1/19/2017)... ... , ... Cosmetic Town, an online plastic surgery community, begins 2017 with an ... for their readers to get the information they desire. The procedures are now listed ... used on those particular areas. , “We are excited to streamline our listings in ...
(Date:1/19/2017)... NJ (PRWEB) , ... January 19, 2017 , ... ... certified dermatologist by the American Board of Dermatology and fellowship trained Mohs and ... the National Institutes of Health, Dr. Li completed his internship in internal medicine ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... doctor who administered fillers that resulted in severe facial disfiguration. After four frightening ... on by doctors at UCLA Medical Center, who removed the substances in a ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and privacy panel system. , The Tranquility privacy panel system was designed ... office environment. Tranquility panels help reduce noise and provide the visual privacy required ...
Breaking Medicine News(10 mins):